Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Fraser

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
Journal of the International AIDS Society|February 22, 2023
Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysisJack Stone, Rutendo Bothma, Gabriela B Gomez, et al.
BMJ (Clinical Research Ed.)|February 22, 2019
Universal antenatal screening for group B streptococcus may cause more harm than goodFarah Seedat, Julia Geppert, Chris Stinton, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
AIDS (London, England)|September 16, 2022
Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in KenyaJack Stone, Hannah Fraser, Josephine G Walker, et al.
American Journal of Epidemiology|June 1, 2019
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban ComparisonHannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Royal Society Open Science|June 9, 2023
Predicting and reasoning about replicability using structured groupsBonnie C Wintle, Eden T Smith, Martin Bush, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The International Journal on Drug Policy|June 22, 2025
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, VietnamAdam Trickey, Josephine G Walker, Pham Minh Khue, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
Journal of the International AIDS Society|February 22, 2023
Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysisJack Stone, Rutendo Bothma, Gabriela B Gomez, et al.
BMJ (Clinical Research Ed.)|February 22, 2019
Universal antenatal screening for group B streptococcus may cause more harm than goodFarah Seedat, Julia Geppert, Chris Stinton, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
AIDS (London, England)|September 16, 2022
Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in KenyaJack Stone, Hannah Fraser, Josephine G Walker, et al.
American Journal of Epidemiology|June 1, 2019
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban ComparisonHannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Royal Society Open Science|June 9, 2023
Predicting and reasoning about replicability using structured groupsBonnie C Wintle, Eden T Smith, Martin Bush, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The International Journal on Drug Policy|June 22, 2025
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, VietnamAdam Trickey, Josephine G Walker, Pham Minh Khue, et al.
Pageof 9